Aetna's ambiguous definition of “medically necessary” failed to justify its exclusion of proton therapy for treating adult non-metastatic breast or prostate cancer, a judge decided.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}